Predictive factors for failing to achieve a nadir prostate specific antigen of 1.0ng/ml or less after combined androgen blockade

被引：0
|
作者：
Park, S. C.
Jeong, H. J.
Oh, S. J.
Bae, B. J.
Choi, H. Y.
Kim, C. S.
Hong, S. J.
Kim, W. J.
Lee, S., I
Song, J. M.
Yoon, J. H.
Rim, J. S.
机构：
[1] Wonkwang Univ, Iksan, South Korea
[2] Sungkyunkwan Univ, Seoul, South Korea
[3] Univ Ulsan, Seoul, South Korea
[4] Yonsei Univ, Seoul 120749, South Korea
[5] Chungbuk Univ, Cheongju, South Korea
[6] Seoul Natl Univ, Seoul 151, South Korea
[7] Wonju Yonsei Univ, Wonju, South Korea
[8] Dong A Univ, Pusan, South Korea
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2007年 / 6卷 / 02期
关键词：
D O I：
10.1016/S1569-9056(07)60246-2
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：84 / 84
页数：1
相关论文
共 50 条
  • [1] Failing to achieve a nadir prostate-specific antigen after combined androgen blockade: Predictive factors
    Park, Seung Chol
    Rim, Joung Sik
    Choi, Han Yong
    Kim, Choung Soo
    Hong, Sung Joon
    Kim, Wun Jae
    Lee, Sang Eun
    Song, Jae Mann
    Yoon, Jin Han
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2009, 16 (08) : 670 - 675
  • [2] Time to achieve a prostate-specific antigen nadir of ≤0.2 ng/mL and related factors after permanent prostate brachytherapy
    Soyano, Takashi
    Yorozu, Atsunori
    Natsume, Nana
    Hanada, Takashi
    Shiraishi, Yutaka
    Toya, Kazuhito
    Saito, Shiro
    [J]. BRACHYTHERAPY, 2021, 20 (01) : 29 - 37
  • [3] Time to achieve a prostate specific antigen nadir of 0.2 ng./ml. after simultaneous irradiation for prostate cancer
    Critz, FA
    [J]. JOURNAL OF UROLOGY, 2002, 168 (06): : 2434 - 2438
  • [4] Predictive Factors for Prostate Cancer in Biopsy of Patients with Prostate-Specific Antigen Levels Equal to or Less Than 4 ng/ml
    Kim, Hyoung Woo
    Ko, Young Hwii
    Kang, Seok Ho
    Lee, Jeong Gu
    [J]. KOREAN JOURNAL OF UROLOGY, 2011, 52 (03) : 166 - 171
  • [5] Prostate specific antigen velocity in men with total prostate specific antigen less than 4 ng/ml
    Loeb, Stacy
    Roehl, Kimberly A.
    Nadler, Robert B.
    Yu, Xiaoying
    Catalona, William J.
    [J]. JOURNAL OF UROLOGY, 2007, 178 (06): : 2348 - 2352
  • [6] Prostate-specific antigen nadir of 0.5 ng/ml or less defines disease freedom for surgically staged men irradiated for prostate cancer
    Critz, FA
    Levinson, K
    Williams, WH
    Holladay, D
    Holladay, C
    Griffin, V
    [J]. UROLOGY, 1997, 49 (05) : 668 - 672
  • [7] The risk of rapid prostate specific antigen increase in men with baseline prostate specific antigen 2.0 ng/ml or less
    Ito, K
    Yamamoto, T
    Suzuki, K
    Kurokawa, K
    Yamanaka, H
    [J]. JOURNAL OF UROLOGY, 2004, 171 (02): : 656 - 660
  • [8] PROSTATE-SPECIFIC ANTIGEN NADIR AND TIME TO PROSTATE-SPECIFIC ANTIGEN NADIR FOLLOWING MAXIMAL ANDROGEN BLOCKADE INDEPENDENTLY PREDICT THE PROGNOSIS IN PATIENTS WITH METASTATIC PROSTATE CANCER
    Sun, I
    Seok, Y.
    Dea, S.
    Hyun, S.
    Young, S.
    Se, J.
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 : 362 - 362
  • [9] Prostate-Specific Antigen Nadir and Time to Prostate-Specific Antigen Nadir Following Maximal Androgen Blockade Independently Predict Prognosis in Patients with Metastatic Prostate Cancer
    Hong, Seok Young
    Cho, Dae Sung
    Kim, Sun Il
    Ahn, Hyun Soo
    Kim, Se Joong
    [J]. KOREAN JOURNAL OF UROLOGY, 2012, 53 (09) : 607 - 613
  • [10] Predictive value of prostate specific antigen nadir after salvage cryotherapy
    Greene, GF
    Pisters, LL
    Scott, SM
    von Eschenbach, AC
    [J]. JOURNAL OF UROLOGY, 1998, 160 (01): : 86 - 90
12345